Fuminori Kato

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignee: Ishihara Sangyo Kaisha, Ltd.. Active years: 1995-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fuminori Kato. Retrieved from https://idiyas.com/inventor/fuminori-kato-1n6tftke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 25.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 59(Granted Patents)

Location History:

Shiga, JP (2002 - 2006)
Kusatsu, JP (1995 - 2014)
Osaka, JP (2022)

Company Filing History:

8 out of 394

Ishihara Sangyo Kaisha, Ltd.

patents

Years Active: 1995-2022

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11246309 - Preserving agent for organs or tissue and preservation method for organs or tissue (2022-02-15),

2. 8691956 - Monoclonal antibody against human HIG-1 polypeptide (2014-04-08),

3. 7632865 - Thioamides and salts thereof and cytokine production inhibitors containing both (2009-12-15),

4. 7132546 - Aniline derivatives or salts thereof and cytokine production inhibitors containing the same (2006-11-07),

5. 7067520 - Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts (2006-06-27),

6. 6596863 - Medical composition containing nitroetheneamine Derivative or salt there of as active constituent (2003-07-22),

7. 6451792 - Medical composition containing nitroetheneamine derivative or salt thereof as active constituent (2002-09-17),

8. 5380834 - Immuno-suppressive agent (1995-01-10),

Title: Fuminori Kato: Innovator in Organ Preservation and Monoclonal Antibodies

Introduction

Fuminori Kato is a distinguished inventor based in Shiga, Japan. He has made significant contributions to the fields of organ preservation and biotechnology. With a total of 8 patents to his name, Kato's work is recognized for its innovative approaches to critical medical challenges.

Latest Patents

Kato's latest patents include a preserving agent for organs or tissue and a preservation method for organs or tissue. This invention discloses a preserving agent that comprises (A) quercetin, and (B) at least one sugar selected from the group consisting of fructose and sucrose. The preservation method involves immersing an organ or tissue in a liquid mixture containing these components. Another notable patent is a monoclonal antibody against the human HIG-1 polypeptide. This invention relates to an antibody that binds to at least one epitope included in the amino acid sequence at positions 1-19 of the human HIG-1 polypeptide. It also includes an antibody fragment, a DNA sequence encoding a variable region of the antibody, and a method for detecting the human HIG-1 polypeptide.

Career Highlights

Fuminori Kato is currently associated with Ishihara Sangyo Kaisha, Ltd., where he continues to innovate and develop new technologies. His work has had a profound impact on the medical field, particularly in organ preservation techniques.

Collaborations

Kato has collaborated with notable colleagues such as Hirohiko Kimura and Kazuhiro Yamamoto. Their combined expertise has contributed to the advancement of Kato's research and inventions.

Conclusion

Fuminori Kato's contributions to organ preservation and biotechnology exemplify the spirit of innovation in the medical field. His patents reflect a commitment to improving health outcomes through scientific advancement.

Profile summary based on public USPTO records.